Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study builds on a successful collaboration and will compare T cell and antibody responses to uncover the role of ‘background’ immunity to virus strains already in circulation, including infections with similar coronaviruses.

The study is led by Professor Graham Ogg, who currently heads the MRC Human Immunology Unit at the MRC Weatherall Institute of Molecular Medicine, and Professor Neelika Malavige at the University of Sri Jayewardenepura. Professor Malavige is also a visiting researcher at Oxford University.

“We have worked together for 12 years to understand the response to dengue infections, and we now want to bring the expertise and knowledge we’ve acquired to understand the immune responses in individuals with COVID-19,” said Professor Ogg.

Current research indicates that immune responses to the novel SARS-CoV2 may be a key that distinguishes only a mild illness after infection from a more serious condition, but the workings of these immune responses are still poorly understood.

By comparing immune markers in blood samples from the UK versus Sri Lanka, the researchers hope to understand how existing immunity to different viruses (including other coronaviruses) might influence the immune response to a COVID-19 infection.

Read more on the Radcliffe Department of Medicine website

Similar stories

Oxford announces the founding of the new Bennett Institute for Applied Data Science

The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes.

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

'Finding our Way: An NHS Tribute Garden' at RHS Chelsea Flower Show 2021

‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. The garden is designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.